Please login to the form below

Not currently logged in
Email:
Password:

Andrew Lansley becomes Health Secretary

Andrew Lansley has been appointed as Secretary of State for Health, under the Conservative-Liberal Democrat coalition government

Andrew Lansley has been appointed to the role of Secretary of State for Health, under David Cameron's newly formed Conservative-Liberal Democrat coalition government.

 Andrew Lansley, secretary of state for health
Andrew Lansley, Secretary of State for Health
(Picture: Conservative party)


Lansley held the position of Shadow Secretary of State for Health since 2003 under the Conservative's then party leader, Michael Howard. In 2008, he was named the eighth most influential person in the Health Service Journal (HSJ)'s report: 'Fifty People with the Greatest Influence on Today's NHS Policy and Practice'.

Lansley will take over the post from outgoing Health Secretary Andy Burnham, who was appointed to the position in June 2009.

The Conservatives and Liberal Democrats have published a coalition agreement document outlining agreements reached between the two parties on a range of issues. With regards to health, the coalition state: "The parties agree that funding for the NHS should increase in real terms in each year of the Parliament, while recognising the impact this decision would have on other departments." A more detailed document is expected to follow.

12th May 2010

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics